Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : The Thread Formerly Known as No Rest For The Wicked -- Ignore unavailable to you. Want to Upgrade?

To: kathyh who wrote (50761)	6/11/1999 8:26:00 AM
From: Jack Colton	Read Replies (1) \| Respond to of 90042

Thanks for the 'Heads Up' on NSOL. I won't be playing it today. At least not long...

To: kathyh who wrote (50761)	6/11/1999 9:00:00 AM
From: cirrus	Read Replies (2) \| Respond to of 90042

CNTO - "I think it's pretty much a done deal that these guys will be taken out. It's just a question of who will do it, when it will happen and how much they will pay." ...Akhtar Samad, Oscar Gruss & Son biotechnology analyst. (from Yahoo, date & source unknown) "Centocor is in play. I'd be surprised if someone else doesn't step up to the plate and make a bid. My sense is that J&J is trying to figure out what they have to pay for Centocor." ...Larry Feinberg, a managing partner at Oracle Partners, which operates health-care hedge funds (WSJ, 5/13/99)